Mindfulness-Oriented Recovery Enhancement (MORE) in Heroin Addiction

Completed · Not applicable

Conditions studied: Opiate Use Disorder

In brief

In this study, neuroimaging of reward processing, drug cue reactivity and inhibitory control is used before and immediately after 8 weeks of two types of group therapy in individuals with opioid addiction; clinical outcomes will be assessed before, immediately and three months after treatment. Results could point to factors that track and predict recovery with treatment, offering clinicians markers that can be used for enhancing precision medicine with the goal of reducing morbidity and mortality associated with opiate addiction.

Key facts

Study ID
NCT04112186
Run by
Icahn School of Medicine at Mount Sinai
People needed
157
Starts
2020-06-21
Expected to finish
2024-09-11
Last updated by the study team
2026-07-24

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.